This study aims to determine if varenicline (Chantix®), currently used as a smoking cessation
aid, will decrease the likelihood of relapse to smoking following a programmed lapse in the
laboratory. The hypothesis is that varenicline will reduce the reinforcing effects of smoking
and will delay or prevent relapse compared to placebo.